Florida’s surgeon general is accusing the Biden administration of “actively preventing the effective distribution of monoclonal antibody treatments” in the United States.
NEW: Florida Surgeon General says Biden Admin is "actively preventing" distribution of monoclonal antibodies by pausing shipments of Regeneron, in letter to HHS Sec.
— Jay O'Brien (@jayobtv) December 28, 2021
Feds paused Regeneron bc it may not work against Omicron. FL says it can still be used in existing Delta cases. pic.twitter.com/9mmw5SsuZJ
State Surgeon General Joseph Ladapo made the assertion in a letter Tuesday (Dec. 28) to Secretary of Health and Human Services Xavier Becerra following the administration recently pausing shipments of COVID-19 antibody treatments, arguing they are not effective against the Omicron variant of SARS-CoV-2.
Those halted for distribution were made by drug companies Regeneron and Eli Lilly. However, the federal government continues to supply Sotrovimab, a monoclonal antibody from the company GlaxoSmithKline, which reportedly works against the Omicron variant.